FENO and AHR mannitol in patients referred to an out-of-hospital asthma clinic: a real-life study

References

• Thomsen SF, Ulrik CS, Kyvik KO, Larsen K, Skadhauge LR, Steffensen I, Backer V. The incidence of asthma in young adults. Chest 2005;127:1928–1934
   PubMed Web of Science ®Google Scholar
• Nolte H, Nepper-Christensen S, Backer V. Unawareness and undertreatment of asthma and allergic rhinitis in a general population. Respir Med 2006;100:354–362
   PubMed Web of Science ®Google Scholar
• van Weel C, Bateman ED, Bousquet J, Reid J, Grouse L, Schermer T, Valovirta E, Zhong N. Asthma management pocket reference 2008. Allergy 2008;63:997–1004
   PubMed Web of Science ®Google Scholar
• Boulet LP, Fitzgerald JM, Levy ML, Cruz AA, Pedersen S, Haahtela T, Bateman ED. A guide to the translation of the Global Initiative for Asthma (GINA) strategy into improved care. Eur Respir J 2012;39:1220–1229
   PubMed Web of Science ®Google Scholar
• Smith AD, Taylor DR. Is exhaled nitric oxide measurement a useful clinical test in asthma? Curr Opin Allergy Clin Immunol 2005;5:49–56
   PubMed Web of Science ®Google Scholar
• Porsbjerg C, Lund TK, Pedersen L, Backer V. Inflammatory subtypes in asthma are related to airway hyperresponsiveness to mannitol and exhaled NO. J Asthma 2009;46:606–612
   PubMed Web of Science ®Google Scholar
• Sverrild A, Porsbjerg C, Backer V. The use of inhaled mannitol in the diagnosis and management of asthma. Expert Opin Pharmacother 2012;13:115–123
   PubMed Web of Science ®Google Scholar
• Brannan JD, Koskela H, Anderson SD, Chan HK. Budesonide reduces sensitivity and reactivity to inhaled mannitol in asthmatic subjects. Respirology 2002;7:37–44
   PubMed Web of Science ®Google Scholar
• Sverrild A, Porsbjerg C, Thomsen SF, Backer V. Airway hyperresponsiveness to mannitol and methacholine and exhaled nitric oxide: a random-sample population study. J Allergy Clin Immunol 2010;126:952–8
   PubMed Web of Science ®Google Scholar
• Sverrild A, Malinovschi A, Porsbjerg C, Backer V, Alving K. Predicting airway hyperreactivity to mannitol using exhaled nitric oxide in an unselected sample of adolescents and young adults. Respir Med 2013;107:150–152
   PubMed Web of Science ®Google Scholar
• Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, Olin AC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011;184:602–615
   PubMed Web of Science ®Google Scholar
• O'Byrne PM. Global guidelines for asthma management: summary of the current status and future challenges. Pol Arch Med Wewn 2010;120:511–517
   PubMed Web of Science ®Google Scholar
• Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M, Gibson P, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008;31:143–178
   PubMed Web of Science ®Google Scholar
• Bousquet J, Schunemann HJ, Zuberbier T, Bachert C, Baena-Cagnani CE, Bousquet PJ, Brozek J, et al. Development and implementation of guidelines in allergic rhinitis – an ARIA-GA2LEN paper. Allergy 2010;65:1212–1221
   PubMed Web of Science ®Google Scholar
• Dreborg S, Belin L, Eriksson NE, Grimmer O, Kunkel G, Malling HJ, Nilsson G, et al. Results of biological standardization with standardized allergen preparations. Allergy 1987;42:109–116
   PubMed Web of Science ®Google Scholar
• Brannan JD, Anderson SD, Perry CP, Freed-Martens R, Lassig AR, Charlton B. The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline. Respir Res 2005;6:144
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Dweik RA, Gelb AF, Gibson PG, George SC, Grasemann H, Pavord ID, et al. Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest 2010;138:682–692
   PubMed Web of Science ®Google Scholar
• Aronsson D, Tufvesson E, Bjermer L. Comparison of central and peripheral airway involvement before and during methacholine, mannitol and eucapnic hyperventilation challenges in mild asthmatics. Clin Respir J 2011;5:10–18
   PubMed Web of Science ®Google Scholar
• Sue-Chu M, Brannan JD, Anderson SD, Chew N, Bjermer L. Airway hyperresponsiveness to methacholine, adenosine 5-monophosphate, mannitol, eucapnic voluntary hyperpnoea and field exercise challenge in elite cross-country skiers. Br J Sports Med 2010;44:827–832
   PubMed Web of Science ®Google Scholar
• Haughney J, Price D, Kaplan A, Chrystyn H, Horne R, May N, Moffat M, et al. Achieving asthma control in practice: understanding the reasons for poor control. Respir Med 2008;102:1681–1693
   PubMed Web of Science ®Google Scholar
• Sverrild A, Porsbjerg C, Thomsen SF, Backer V. Airway hyperresponsiveness to mannitol and methacholine and exhaled nitric oxide: a random-sample population study. J Allergy Clin Immunol 2010;126:952–958
   PubMed Web of Science ®Google Scholar